Fautrel, Bruno <br/><br/>
Regression of subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis treated with a biologic tumor necrosis factor alpha-blocking agent: comment on the article by Pisetsky and the letter from Aringer et al.  [electronic resource] 

 -  Arthritis and rheumatism  May 2002 
 - 1408-9; author reply 1409 p.  digital 
<br/><br/> Publication Type: Case Reports; Comment; Letter 
<br/><br/><label>ISSN: </label>0004-3591 
<br/><br/><label>Standard No.: </label>10.1002/art.10271  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antirheumatic Agents--pharmacology<br/>Arthritis, Rheumatoid--complications<br/>Etanercept<br/>Female<br/>Humans<br/>Immunoglobulin G--pharmacology<br/>Lupus Erythematosus, Cutaneous--complications<br/>Receptors, Tumor Necrosis Factor<br/>Remission Induction<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors